Tell us what's important to you. We'll build you a better ClevelandClinic.org.

close

Take the ClevelandClinic.org Improvement Survey Now!

Online Health Chat.Access Our A-Z Phone Directorybenefiting the communityOnline Health Chat.

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage

Print this ContentEmail this Content
Study:

The Evaluation of Patients With Acute Hypertension and Intracerebral Hemorrhage With Intravenous Clevidipine Treatment

Rationale:

n/a

Purpose:

The purpose of this study is to determine the efficacy and safety of clevidipine for treating acute hypertension (high blood pressure, defined as systolic blood pressure >160 mmHg) in patients with intracerebral hemorrhage (i.e., bleeding in the brain; stroke).

Study Status: Recruiting

Recruiting:
Gwendolyn Lynch, MD 216-312-4659 lynchg@ccf.org

Condition Intervention Phase
Hypertension
Hemorrhage		 Drug: Clevidipine butyrate injectable emulsion Phase 3

Verified by The Medicines Company August, 2008

Sponsored by: The Medicines Company
Information provided by: The Medicines Company
ClinicalTrials.gov identifier: NCT00666328

Study Type: Interventional

Study Design: Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study

Cleveland Clinic Hospitals
Cleveland, Ohio 44195
United States

Carmelo Graffagnino, MD., Principal Investigator

This information is abbridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.